A pharmaceutical composition comprising a P2X7-receptor antagonist and a tumour necrosis factor alpha

Details for Australian Patent Application No. 2004243137 (hide)

Owner AstraZeneca AB

Inventors Boughton-Smith, Nigel

Agent Freehills

Pub. Number AU-B-2004243137

PCT Pub. Number WO2004/105798

Priority 0312321.3 29.05.03 GB; 0301655-7 05.06.03 SE

Filing date 27 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 27 September 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/465 (2006.01) - Nicotine

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105798 Priority application(s): WO2004/105798

27 September 2007 Application Accepted

  Published as AU-B-2004243137

24 January 2008 Standard Patent Sealed

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243139-Drape product for surgical interventions

2004243133-New product